doi:10.1016/j.nut.2023.112350
The great improvement detected in ED degree category should be regarded with caution considering that, in the l-ARG cohort, only 24% of patients, mainly belonging to the baseline category of mild ED, reached IIEF-6 scores compatible with absence of ED, whereas the majority of patients improved the category by remaining within the range of ED
DiMarchis quote as follows: Many diseases share the same root causes, which is inhibition of AMPK activity leading to disruption of many metabolic pathways. GLP-1 drugs activate AMPK primarily through reducing calorie intake
24 and 48 hours) increases the total ERK1/2 levels in a dose-dependent manner, and ERK1/2 activation is observed specifically at 10 -5 M in HemSCs [4]
This action helps to prolong the feeling of fullness after eating, which not only aids in appetite control but also contributes to weight loss by reducing overall calorie intake
Neuron 108 , 11461162.e1110 (2020)